ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 322 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $445,000 | +20.9% | 4,791 | -22.6% | 0.01% | +25.0% |
| Q3 2021 | $368,000 | -93.4% | 6,191 | -92.4% | 0.01% | -92.0% |
| Q2 2021 | $5,537,000 | -22.3% | 81,205 | -20.9% | 0.10% | -24.2% |
| Q1 2021 | $7,125,000 | +202.4% | 102,709 | +234.8% | 0.13% | +135.7% |
| Q4 2020 | $2,356,000 | -3.0% | 30,679 | -5.6% | 0.06% | -39.1% |
| Q3 2020 | $2,428,000 | +887.0% | 32,484 | +729.7% | 0.09% | +607.7% |
| Q2 2020 | $246,000 | +68.5% | 3,915 | +12.5% | 0.01% | +30.0% |
| Q1 2020 | $146,000 | -11.5% | 3,480 | 0.0% | 0.01% | -9.1% |
| Q4 2019 | $165,000 | +38.7% | 3,480 | +33.6% | 0.01% | +10.0% |
| Q3 2019 | $119,000 | – | 2,604 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 163,133 | $7,467,000 | 4.14% |
| PFM Health Sciences, LP | 2,271,536 | $103,968,000 | 3.07% |
| Partner Investment Management, L.P. | 28,877 | $1,322,000 | 2.26% |
| Atika Capital Management LLC | 181,000 | $8,284,000 | 1.74% |
| DAFNA Capital Management LLC | 93,942 | $4,300,000 | 1.62% |
| Asymmetry Capital Management, L.P. | 16,272 | $745,000 | 1.60% |
| First Light Asset Management, LLC | 190,838 | $8,735,000 | 1.32% |
| Perceptive Advisors | 953,129 | $43,624,000 | 1.18% |
| Rhenman & Partners Asset Management AB | 155,000 | $7,094,000 | 0.89% |
| Opus Point Partners Management, LLC | 9,770 | $447,000 | 0.81% |